Related Experiment Video
Updated: May 3, 2026

Assessment of Child Anthropometry in a Large Epidemiologic Study
Published on: February 2, 2017
Waist-to-height ratio, inflammation and CVD risk in obese children
Josune Olza1, Concepcion M Aguilera1, Mercedes Gil-Campos2
11Department of Biochemistry and Molecular Biology II,Institute of Nutrition and Food Technology,Centre for Biomedical Research (CIB),Lab 123,University of Granada,Avda. del Conocimiento s/n,18016 Armilla,Granada,Spain.
Insights
Waist-to-height ratio (WHtR) is linked to inflammation and cardiovascular disease (CVD) risk in obese children. Early biomarker changes in obese youth may predict future metabolic issues.
Area of Science:
- Pediatrics
- Cardiovascular Health
- Metabolic Syndrome
Background:
- Childhood obesity is a growing concern with potential long-term health implications.
- Central obesity, indicated by waist-to-height ratio (WHtR), is associated with metabolic disturbances.
- Prepubertal children are at risk for developing early markers of inflammation and cardiovascular disease (CVD).
Purpose of the Study:
- To investigate the association between waist-to-height ratio (WHtR) and biomarkers of inflammation, CVD risk, and endothelial dysfunction.
- To assess these associations specifically in prepubertal obese children compared to normal-weight peers.
Main Methods:
- A prospective, multicentre case-control study involving 446 Caucasian prepubertal children (aged 6-12 years).
- Participants were categorized into normal-weight (n=223) and obese (n=223) groups, matched for age and sex.
- Measurements included WHtR, blood pressure, various plasma biomarkers (lipids, cytokines, adhesion molecules), and glucose levels.
Main Results:
- Obese children exhibited significantly higher WHtR, blood pressure, and numerous inflammatory and CVD risk biomarkers compared to normal-weight children.
- Resistin, tumor necrosis factor-alpha (TNF-α), and active plasminogen activator inhibitor-1 were significantly associated with WHtR.
- Adiponectin and HDL-cholesterol levels were lower in obese children, while glucose showed no difference.
Conclusions:
- Elevated WHtR in prepubertal obese children is associated with increased inflammation and CVD risk markers.
- These findings suggest that metabolic alterations related to obesity begin before puberty.
- Early identification and intervention in obese children are crucial to mitigate future cardiovascular and metabolic consequences.
Objective:
To evaluate the association between waist-to-height ratio (WHtR) and specific biomarkers of inflammation, CVD risk and endothelial dysfunction in prepubertal obese children.
Design:
Prospective, multicentre case-control study matched by age and sex.
Setting:
Children were recruited between May 2007 and May 2010 from primary-care centres and schools in three cities in Spain (Cordoba, Santiago de Compostela and Zaragoza).
Subjects:
Four hundred and forty-six (223 normal weight and 223 obese) Caucasian prepubertal children aged 6-12 years.
Results:
WHtR was higher in the obese than in the normal-weight children. Blood pressure, waist circumference, weight, height, insulin, plasma lipids, leptin, resistin, abnormal neutrophil and monocyte counts, C-reactive protein, IL-6, IL-8, TNF-α, myeloperoxidase, soluble intercellular adhesion molecule-1, selectin and plasminogen activator inhibitor-1 levels were higher in the obese than in the normal-weight group. Adiponectin and HDL-cholesterol were lower and glucose and metalloproteinase-9 showed no differences. Resistin, TNF-α and active plasminogen activator inhibitor-1 were associated with WHtR, a sensitive indicator of central obesity.
Conclusions:
Our results lead to the hypothesis that changes in biomarker levels of insulin resistance, inflammation and CVD risk before puberty might induce metabolic consequences of obesity in obese children before reaching adulthood.
Related Concept Videos
Obesity
Drug Dosing: Obese Patients
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Cholesterol: Significance and Regulation
Considering cholesterol and...
Coronary Artery Disease I: Introduction
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

